COVID Lessons Learned: Sustainable Regional Manufacture to Achieve Health Equity & Security

COVID exposed worldwide health inequalities and security challenges. Consequently WHO, WTO and other entities are calling for regional diversification of vaccines and drug manufacturing. For this to be sustainable there has to be strong demand from countries and multilateral procurement agencies.

Chair: - Mathew Cherian, VP of Operations and R&D, ReVive Biotechnology, USA

Co-moderator: - Nikolina Biskic, Regulatory Affairs Manager, Switzerland

Panellist: - Stavros Nicolaou, Group Senior Executive, Aspen Pharmacare Holdings, South Africa